Nervous System News and Research

Latest Nervous System News and Research

Actavis releases generic version of Pulmicort RESPULES

Actavis plc today announced that it has launched its generic version of AstraZeneca's Pulmicort RESPULES® (budesonide inhalation suspension) 0.25 and 0.5 mg vials following a ruling from the United States District Court for the District of New Jersey that (i) United States Patent No. 7,524,834 is invalid, and (ii) AstraZeneca's request for a permanent injunction is denied.

13 Feb 2015

Thync electrical neurosignaling reduces brain's response to stress, shows study

Thync today announced results from a study published via bioRxiv that show electrical neurosignaling delivered by its consumer wearable device reduces the brain's response to stress in a chemical-free manner.

13 Feb 2015

Stem cell transplants more effective than mitoxantrone drug for people with severe multiple sclerosis

Stem cell transplants may be more effective than the drug mitoxantrone for people with severe cases of multiple sclerosis (MS), according to a new study published in the February 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

12 Feb 2015

RAB3GAP complex plays important role in autophagy

Neurodegenerative disorders such as Alzheimer's disease are typically characterized by protein deposits in the brain. These are comprised of defective, insoluble proteins which no longer fulfill their function and which cells are unable to break down. The work group headed by Professor Christian Behl of the Institute of Pathobiochemistry of the University Medical Center of Johannes Gutenberg University Mainz has determined the RAB3GAP complex as a novel factor that influences the efficient degradation of proteins.

12 Feb 2015

ADDF, Pfizer's CTI collaborate to advance development of new drugs for Alzheimer's disease

The Alzheimer's Drug Discovery Foundation and Pfizer's Centers for Therapeutic Innovation announced today a collaboration designed to advance the development of new small-molecule drugs for Alzheimer's disease and related dementias. As part of the first-of-its kind collaboration in Alzheimer's, the ADDF and CTI will jointly invest in translational research projects, with a focus on novel Alzheimer's drug targets.

11 Feb 2015

First human clinical study of ChromaDex's NIAGEN nicotinamide riboside meets primary endpoint

ChromaDex Corp. announced today that the initial results of the first human clinical study for the company's NIAGEN nicotinamide riboside (NR) has met its primary endpoint.

11 Feb 2015

UC San Diego School of Medicine project receives 2015 Avant-Garde Award for HIV/AIDS Research

A University of California, San Diego School of Medicine project involving the creation of miniature models of the human brain - developed with stem cells - to study neurological disorders caused by HIV and methamphetamine use has been named one of five recipients of the 2015 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse.

11 Feb 2015

UM one step closer to developing potential drug for treating brain cancer

Promentis Pharmaceuticals, Inc. recently announced it will enter an exclusive agreement with UM to commercialize a discovery made by a team of UM faculty scientists that has the potential to treat brain cancer and possibly other disorders of the central nervous system.

11 Feb 2015

TUSM researchers awarded $7.4 million to study brain impairment in patients infected with HIV

Researchers at Temple University School of Medicine have been awarded a $7.4 million, five-year grant from the National Institute on Drug Abuse to determine how cocaine and HIV-1 interact to cause brain impairment in patients infected with the human immunodeficiency virus.

11 Feb 2015

Epigem contribute to PhD research into Multiple Sclerosis

Epigem, a high-tech British micro engineering company, is supporting research into Multiple Sclerosis (MS) with a new PhD programme to create a novel drug screening platform. This will accelerate the production of MS models and pre-clinical drug development, in order to understand better the disease process and its periods of remission.

10 Feb 2015

Andor Zyla sCMOS Camera enables instantaneous imaging of neuronal activity across whole organism for the first time

The speed, resolution and sensitivity of the Andor Zyla sCMOS camera has allowed the Vaziri research group in Vienna, Austria, to simultaneously image neuronal activity across an entire organism for the first time.

10 Feb 2015

Chiasma announces publication of octreotide capsules Phase III study results in JCEM

Chiasma Inc., a U.S. privately-held biopharma company, announced today that results from a multicenter Phase III study of the investigational new drug, octreotide capsules, were published online for early release on Feb. 9, ahead of print, by the Journal of Clinical Endocrinology & Metabolism.

10 Feb 2015

Three groups of researchers receive BRAIN Initiative funding to improve artificial limb technology

Three groups of researchers who have received support from the National Institutes of Health will obtain funding from the President's BRAIN Initiative to improve artificial limb technology. The new awards will be funded and administered by the Defense Advanced Research Projects Agency and will build on the fundamental discoveries that were made possible by NIH support.

10 Feb 2015

Five researchers selected to receive 2015 Avant-Garde Award for HIV/AIDS Research

With proposals ranging from innovative therapies to the development of unique organoid models of the brain, five scientists have been selected to receive the 2015 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse, part of the National Institutes of Health. The five scientists will each receive $500,000 per year for five years to support their research.

10 Feb 2015

Researchers document pathological progress of multiple sclerosis

The Centre for Brain Research at the MedUni Vienna is regarded as a world leader in researching the mechanisms involved with multiple sclerosis (MS). Now, in a paper published in the highly respected journal Lancet Neurology, an international team of researchers from Edinburgh, Cleveland and Vienna, under the leadership of Hans Lassmann, Head of the Department of Neuroimmunology at the MedUni Vienna, has for the first time documented the pathological progress of the disease from its early to late stage and also shown that inflammatory and neurodegenerative processes have a role to play.

9 Feb 2015

Oncolytics Biotech submits Orphan Drug Designation for high grade gliomas in pediatric patients

Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.

9 Feb 2015

New study sheds light on anorexia nervosa

A study led by Howard Steiger, PhD, head of the Douglas Mental Health University Institute Eating Disorders Program, in Montreal, in collaboration with Linda Booij, a researcher with Sainte-Justine Hospital and an assistant professor at Queen's University, is the first to observe effects suggesting that the longer one suffers from active anorexia nervosa (AN), the more likely they are to show disorder-relevant alterations in DNA methylation.

9 Feb 2015

Study highlights the need for more research on trauma and other body-mind therapies

In a Theory and Hypothesis paper titled "Somatic Experiencing: Using Interoception and Proprioception as Core Elements of Trauma Therapy," published today in Frontiers in Psychology, Dartmouth investigators Peter Payne, SEP, and Mardi Crane-Godreau, PhD, note the lack of hypothesized scientific models for the mechanisms of action responsible for outcomes in Somatic Experiencing® (SE) trauma therapy and other body-mind therapies.

9 Feb 2015

UVA researchers find biological trigger for protective form of immune response to spinal cord injury

Hot on the heels of discovering a protective form of immune response to spinal cord injury, researchers at the University of Virginia School of Medicine have pinpointed the biological trigger for that response - a vital step toward being able to harness the body's defenses to improve treatment for spine injuries, brain trauma, Alzheimer's disease and other neurodegenerative conditions.

8 Feb 2015

Research findings could lead to improved treatments for brain and spinal cord injuries

6 Feb 2015

Nervous System News and Research

Latest Nervous System News and Research

Actavis releases generic version of Pulmicort RESPULES

Thync electrical neurosignaling reduces brain's response to stress, shows study

Stem cell transplants more effective than mitoxantrone drug for people with severe multiple sclerosis

RAB3GAP complex plays important role in autophagy

ADDF, Pfizer's CTI collaborate to advance development of new drugs for Alzheimer's disease

First human clinical study of ChromaDex's NIAGEN nicotinamide riboside meets primary endpoint

UC San Diego School of Medicine project receives 2015 Avant-Garde Award for HIV/AIDS Research

UM one step closer to developing potential drug for treating brain cancer

TUSM researchers awarded $7.4 million to study brain impairment in patients infected with HIV

Epigem contribute to PhD research into Multiple Sclerosis

Andor Zyla sCMOS Camera enables instantaneous imaging of neuronal activity across whole organism for the first time

Chiasma announces publication of octreotide capsules Phase III study results in JCEM

Three groups of researchers receive BRAIN Initiative funding to improve artificial limb technology

Five researchers selected to receive 2015 Avant-Garde Award for HIV/AIDS Research

Researchers document pathological progress of multiple sclerosis

Oncolytics Biotech submits Orphan Drug Designation for high grade gliomas in pediatric patients

New study sheds light on anorexia nervosa

Study highlights the need for more research on trauma and other body-mind therapies

UVA researchers find biological trigger for protective form of immune response to spinal cord injury

Research findings could lead to improved treatments for brain and spinal cord injuries

Everything you need to know about epilepsy eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Nervous System News and Research

Latest Nervous System News and Research

Everything you need to know about epilepsy eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in